| 2022-05-17 | Sale | Evolus, Inc. EOLS | See Remarks | 52,015 0.0826% | $12.42 | $646,026 | -36.23% | |
| 2022-03-08 | Sale | Evolus, Inc. EOLS | See Remarks | 10,192 0.0184% | $9.73 | $99,121 | +3.22% | |
| 2021-08-10 | Sale | Evolus, Inc. EOLS | See Remarks | 14,293 0.0259% | $11.18 | $159,774 | -15.91% | |
| 2021-01-25 | Sale | Evolus, Inc. EOLS | See Remarks | 5,398 0.0155% | $7.46 | $40,269 | +30.14% | |
| 2019-05-31 | Sale | Evolus, Inc. EOLS | See Remarks | 5,224 0.019% | $13.53 | $70,704 | -0.37% | |
| 2018-05-22 | Sale | Revance Therapeutics, Inc. RVNC | CFO & CBO | 5,748 0.0158% | $30.25 | $173,849 | -28.52% | |
| 2018-03-22 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 6,862 0.0192% | $30.85 | $211,678 | -18.43% | |
| 2018-03-13 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 51,734 0.0912% | $21.60 | $1.12M | -23.31% | |
| 2018-03-09 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 20,000 0.035% | $20.60 | $412,000 | -19.62% | |
| 2018-03-07 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 20,000 0.0356% | $20.10 | $402,000 | -16.06% | |
| 2017-11-07 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 10,000 0.0317% | $26.83 | $268,267 | +9.42% | |
| 2017-10-12 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 11,164 0.0351% | $26.67 | $297,760 | +9.01% | |
| 2017-05-22 | Sale | Revance Therapeutics, Inc. RVNC | CFO, CBO & Secretary | 1,793 0.006% | $20.20 | $36,212 | +34.28% | |
| 2014-12-11 | Revance Therapeutics, Inc. RVNC | CFO, Secretary & EVP Corp Dev. | 980 0.0042% | $17.74 | $17,383 | +53.99% |